LIVIVO - Suchergebnisse -

Suchergebnis

Treffer 1 - 10 von insgesamt 14

Suchoptionen

Artikel ; Online: The burden of neck pain among adults aged 70 years and older in Iran, 1990-2019.

Nejadghaderi, Seyed Aria / Mousavi, Seyed Ehsan / Sullman, Mark J M / Kolahi, Ali-Asghar / Namazi Shabestari, Alireza / Safiri, Saeid

Health science reports

2023 Band 6, Heft 11, Seite(n) e1477

Abstract: Background: Neck pain is a complex musculoskeletal disorder that can result in substantial morbidity. The present article presents the neck pain burden in Iranians who were at least 70 years old, from 1990 to 2019, by sex, age group, and province.: ... ...

Abstract	Background: Neck pain is a complex musculoskeletal disorder that can result in substantial morbidity. The present article presents the neck pain burden in Iranians who were at least 70 years old, from 1990 to 2019, by sex, age group, and province. Methods: Publicly available information on the prevalence, incidence, and years lived with disability (YLD) caused by neck pain was extracted from the Global Burden of Disease study 2019. The estimates were all provided as counts and age-standardized rates (per 100,000), and included 95% uncertainty intervals. Results: The point prevalence of neck pain in 2019 was 8710.6, while the incidence rate was 1334.7 per 100,000 population. That same year, there were number of 27.8 thousand YLDs and an YLD rate of 801.7 per 100,000. The prevalence, incidence, and YLD rates did not change substantially over the measurement period (1990-2019). The highest YLD rate was found in Tehran (960.9 per 100,000), while Kohgiluyeh and Boyer-Ahmad had the lowest (730.5 per 100,000). Females had slightly higher prevalent cases, incident cases, and YLDs, as well as their corresponding rates in 2019. In 2019, the number of prevalent cases, incident cases, and YLDs peaked in the 70-74 age group, for both sexes, and in all cases they reduced with age. In both 1990 and 2019, Iran had a higher YLD rate than that found among elderly adults in the Middle East and North Africa region. Conclusions: The burden of neck pain in Iran has decreased slightly over the last three decades, but it still imposes a substantial burden and is higher than that found in the rest of the region. Therefore, preventive programs should be initiated at a young age to reduce the attributable burden later in life.
Sprache	Englisch
Erscheinungsdatum	2023-11-08
Erscheinungsland	United States
Dokumenttyp	Journal Article
ISSN	2398-8835
ISSN (online)	2398-8835
DOI	10.1002/hsr2.1477
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Über subito bestellen

Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

Fernleihe an ZB MED

Sie können sich den gewünschten Titel als lokale Nutzerin oder lokaler Nutzer von ZB MED direkt an den Standort Köln schicken lassen.

Details ▾
- Kostenpflichtig bestellen

Artikel: The Gene Manipulation and Cellular Immunotherapy Combination in the Treatment of Cancer.

Khatami, Fatemeh / Aghamir, Zahra Sadat / Jahanshahi, Fatemeh / Feiz-Abadi, Seyed Ariana / Birang, Fatemeh / Khoshchehreh, Mahdi / Namazi Shabestari, Alireza / Aghamir, Seyed Mohammad Kazem

Iranian journal of biotechnology

2022 Band 20, Heft 2, Seite(n) e3094

Abstract: Context: The immune system is directly linked to the tumors, from tumor formation to the tumor's development and metastasis. So, the interest of scientists over the protective immunological mechanisms has increased and shown gifted strategy in cancer ... ...

Abstract	Context: The immune system is directly linked to the tumors, from tumor formation to the tumor's development and metastasis. So, the interest of scientists over the protective immunological mechanisms has increased and shown gifted strategy in cancer treatment. Evidence acquisition: Genetic engineering and cellular immunotherapy are two different advanced molecular mechanisms to modify the immune responses and genome. Gene manipulation is the bioengineering technology that allows vectors to transfer new genetic information into the target cells. Cellular immunotherapy is an excellent strategy that connects the body's immune system to fight cancer. Results & conclusions: This review described that combination of genetic engineering and cellular immunotherapy has brought the novel antitumor repressive molecules stopping the tumor tissue immune tolerance and significantly expanding cancer therapy's effectiveness. Usually, cell immunotherapy and genetic engineering are considered two independent processes, and, in this review, we believe them in combinations. Here, we review these two novel approaches, and they are both combinations in terms of technological advances and clinical experience.
Sprache	Englisch
Erscheinungsdatum	2022-04-01
Erscheinungsland	Iran
Dokumenttyp	Journal Article ; Review
ZDB-ID	2223669-7
ISSN	2322-2921 ; 1728-3043
ISSN (online)	2322-2921
ISSN	1728-3043
DOI	10.30498/ijb.2022.294933.3094
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Über subito bestellen

Details ▾
- Kostenpflichtig bestellen

Artikel ; Online: Physical Inactivity, Inequalities, and Disparities Across Districts of Iran: A STEPs Survey-Based Analysis.

Hajebi, Amirali / Nasserinejad, Maryam / Azadnajafabad, Sina / Ghasemi, Erfan / Rezaei, Negar / Yoosefi, Moein / Ghamari, Azin / Keykhaei, Mohammad / Ghanbari, Ali / Mohammadi, Esmaeil / Rashidi, Mohammad-Mahdi / Gorgani, Fateme / Moghimi, Mana / Namazi Shabestari, Alireza / Farzadfar, Farshad

Journal of physical activity & health

2023 Band 20, Heft 8, Seite(n) 735–741

Abstract: Background: We aimed to estimate the prevalence of physical inactivity in all districts of Iran and the disparities between subgroups defined by various measures.: Methods: Small area estimation method was employed to estimate the prevalence of ... ...

Abstract	Background: We aimed to estimate the prevalence of physical inactivity in all districts of Iran and the disparities between subgroups defined by various measures. Methods: Small area estimation method was employed to estimate the prevalence of physical inactivity in districts based on the remaining districts in which data on the level of physical inactivity were available. Various comparisons on the estimations were done based on socioeconomic, sex, and geographical stratifications to determine the disparities of physical inactivity among districts of Iran. Results: All districts of Iran had a higher prevalence of physical inactivity compared with the world average. The estimated prevalence of physical inactivity among all men in all districts was 46.8% (95% uncertainty interval, 45.9%-47.7%). The highest and lowest estimated disparity ratio of physical inactivity were 1.95 and 1.14 in males, and 2.25 and 1.09 in females, respectively. Females significantly had a higher prevalence of 63.5% (62.7%-64.3%). Among both sexes, the poor population and urban residents significantly had higher prevalence of physical inactivity than rich population and rural residents, respectively. Conclusions: The high prevalence of physical inactivity among Iranian adult population suggests the urgent need to adopt population-wide action plans and policies to handle this major public health problem and avert the probable burden.
Mesh-Begriff(e)	Adult ; Male ; Female ; Humans ; Sedentary Behavior ; Iran/epidemiology ; Exercise ; Surveys and Questionnaires ; Rural Population ; Prevalence ; Socioeconomic Factors
Sprache	Englisch
Erscheinungsdatum	2023-05-12
Erscheinungsland	United States
Dokumenttyp	Journal Article ; Research Support, Non-U.S. Gov't
ISSN	1543-5474
ISSN (online)	1543-5474
DOI	10.1123/jpah.2022-0113
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Über subito bestellen

Fernleihe an ZB MED

Sie können sich den gewünschten Titel als lokale Nutzerin oder lokaler Nutzer von ZB MED direkt an den Standort Köln schicken lassen.

Details ▾
- Kostenpflichtig bestellen

Artikel ; Online: Effect of the chronic medication use on outcome measures of hospitalized COVID-19 patients: Evidence from big data.

Malekpour, Mohammad-Reza / Abbasi-Kangevari, Mohsen / Shojaee, Ali / Saeedi Moghaddam, Sahar / Ghamari, Seyyed-Hadi / Rashidi, Mohammad-Mahdi / Namazi Shabestari, Alireza / Effatpanah, Mohammad / Nasehi, Mohammadmehdi / Rezaei, Mehdi / Farzadfar, Farshad

Frontiers in public health

2023 Band 11, Seite(n) 1061307

Abstract: Background: Concerns about the role of chronically used medications in the clinical outcomes of the coronavirus disease 2019 (COVID-19) have remarkable potential for the breakdown of non-communicable diseases (NCDs) management by imposing ambivalence ... ...

Abstract	Background: Concerns about the role of chronically used medications in the clinical outcomes of the coronavirus disease 2019 (COVID-19) have remarkable potential for the breakdown of non-communicable diseases (NCDs) management by imposing ambivalence toward medication continuation. This study aimed to investigate the association of single or combinations of chronically used medications in NCDs with clinical outcomes of COVID-19. Methods: This retrospective study was conducted on the intersection of two databases, the Iranian COVID-19 registry and Iran Health Insurance Organization. The primary outcome was death due to COVID-19 hospitalization, and secondary outcomes included length of hospital stay, Intensive Care Unit (ICU) admission, and ventilation therapy. The Anatomical Therapeutic Chemical (ATC) classification system was used for medication grouping. The frequent pattern growth algorithm was utilized to investigate the effect of medication combinations on COVID-19 outcomes. Findings: Aspirin with chronic use in 10.8% of hospitalized COVID-19 patients was the most frequently used medication, followed by Atorvastatin (9.2%) and Losartan (8.0%). Adrenergics in combination with corticosteroids inhalants (ACIs) with an odds ratio (OR) of 0.79 (95% confidence interval: 0.68-0.92) were the most associated medications with less chance of ventilation therapy. Oxicams had the least OR of 0.80 (0.73-0.87) for COVID-19 death, followed by ACIs [0.85 (0.77-0.95)] and Biguanides [0.86 (0.82-0.91)]. Conclusion: The chronic use of most frequently used medications for NCDs management was not associated with poor COVID-19 outcomes. Thus, when indicated, physicians need to discourage patients with NCDs from discontinuing their medications for fear of possible adverse effects on COVID-19 prognosis.
Mesh-Begriff(e)	Humans ; COVID-19 ; SARS-CoV-2 ; Retrospective Studies ; Big Data ; Iran ; Outcome Assessment, Health Care
Sprache	Englisch
Erscheinungsdatum	2023-02-24
Erscheinungsland	Switzerland
Dokumenttyp	Journal Article
ZDB-ID	2711781-9
ISSN	2296-2565 ; 2296-2565
ISSN (online)	2296-2565
ISSN	2296-2565
DOI	10.3389/fpubh.2023.1061307
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Über subito bestellen

Details ▾
- Kostenpflichtig bestellen

Artikel ; Online: The global, regional, and national burden and quality of care index (QCI) of colorectal cancer; a global burden of disease systematic analysis 1990-2019.

Nejadghaderi, Seyed Aria / Roshani, Shahin / Mohammadi, Esmaeil / Yoosefi, Moein / Rezaei, Negar / Esfahani, Zahra / Azadnajafabad, Sina / Ahmadi, Naser / Shahin, Sarvenaz / Kazemi, Ameneh / Namazi Shabestari, Alireza / Khosravi, Ardeshir / Mokdad, Ali H / Larijani, Bagher / Farzadfar, Farshad

PloS one

2022 Band 17, Heft 4, Seite(n) e0263403

Abstract: Background: Colorectal cancer (CRC) is among the five most incident and lethal cancers in world and its burden varies between countries and sexes. We aimed to present a comprehensive measure called the quality of care index (QCI) to evaluate the ... ...

Abstract	Background: Colorectal cancer (CRC) is among the five most incident and lethal cancers in world and its burden varies between countries and sexes. We aimed to present a comprehensive measure called the quality of care index (QCI) to evaluate the inequity and healthcare quality of care regarding CRC by sex and location. Methods: Data on the burden of CRC were extracted from the Global Burden of Disease study 2019. It was transformed to four ratios, including mortality-to-incidence, disability-adjusted life years (DALYs)-to-prevalence, prevalence-to-incidence, and years of life lost (YLLs)-to-years lived with disability (YLDs). Principal component analysis was implemented on the four ratios and the most influential component was considered as QCI with a score ranging from zero to 100, for which higher scores represented better quality of care. Gender Disparity Ratio (GDR) was calculated by dividing QCI for females by males. Results: The global incidence and death numbers of CRC were 2,166,168 (95% uncertainty interval: 1,996,298-2,342,842) and 1,085,797 (1,002,795-1,149,679) in 2019, respectively. Globally, QCI and GDR values were 77.6 and 1.0 respectively in 2019. There was a positive association between the level of quality of care and socio-demographic index (SDI) quintiles. Region of the Americas and African Region had the highest and lowest QCI values, respectively (84.4 vs. 23.6). The QCI values started decreasing beyond the age of 75 in 2019 worldwide. Conclusion: There is heterogeneity in QCI between SDI quintiles. More attention should be paid to people aged more than 75 years old because of the lower quality of care in this group.
Mesh-Begriff(e)	Aged ; Colorectal Neoplasms/epidemiology ; Colorectal Neoplasms/therapy ; Female ; Global Burden of Disease ; Global Health ; Humans ; Incidence ; Male ; Quality of Health Care ; Quality-Adjusted Life Years
Sprache	Englisch
Erscheinungsdatum	2022-04-21
Erscheinungsland	United States
Dokumenttyp	Journal Article
ZDB-ID	2267670-3
ISSN	1932-6203 ; 1932-6203
ISSN (online)	1932-6203
ISSN	1932-6203
DOI	10.1371/journal.pone.0263403
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Über subito bestellen

Details ▾
- Kostenpflichtig bestellen

Artikel ; Online: Twenty-Six-Year Trend of Mortality Rate Due to Ischemic Heart Diseases (IHDs) in Iran: 1990-2015.

Naderimagham, Shohreh / Gohari, Kimiya / Sheidaei, Ali / Jamshidi, Hamidreza / Namazi Shabestari, Alireza / Modirian, Mitra / Rezaei, Nazila / Kompani, Farzad / Damerchilu, Bahman / Bahrami-Taghanaki, Hamidreza / Larijani, Bagher / Farzadfar, Farshad

Iranian journal of public health

2022 Band 51, Heft 2, Seite(n) 416–425

Abstract: Background: Ischemic Heart Diseases (IHDs) are the main causes of deaths all over the world. Since there is no comprehensive study on IHDs mortality rate in Iran, the present study aimed to estimate age-standardized IHDs mortality rate by sex, age, ... ...

Abstract	Background: Ischemic Heart Diseases (IHDs) are the main causes of deaths all over the world. Since there is no comprehensive study on IHDs mortality rate in Iran, the present study aimed to estimate age-standardized IHDs mortality rate by sex, age, geography, and time trends at both national and sub-national levels in Iran. Methods: We used the Death Registration System (DRS) data from 1990 to 2015 collected by the Iranian Ministry of Health and Medical Education across the country, Tehran, and Isfahan main cemetery, not included in the DRS. Utilized death distribution methods to overcome the incompleteness of data. Statistical models including Spatio-temporal and Gaussian-Process Regression models were used to extrapolate all-cause and cause-specific mortality rates. Results: Age-standardized IHDs mortality rate in Iran almost doubled from 1990 to 2015. Forty-nine deaths per 100.000 population in 1990, which increased to 91.6 deaths per 100.000 in 2015). Male to female age-standardized mortality rate increased from 1.07 to 1.32 during the studied period. Aging was associated with an increase in age-standardized IHDs mortality rate in both sexes, all provinces, and all of the years. The range of age-standardized IHDs mortality rate for both sexes was from 58 to 136.2 deaths per 100,000 across provinces in 2015. Conclusion: Due to the increase in age-standardized IHDs mortality rate in Iran, it seems necessary to design and implement appropriate public health interventions by health authorities to prevent and control this group of diseases.
Sprache	Englisch
Erscheinungsdatum	2022-07-14
Erscheinungsland	Iran
Dokumenttyp	Journal Article
ZDB-ID	2240935-X
ISSN	2251-6093 ; 2251-6093
ISSN (online)	2251-6093
ISSN	2251-6093
DOI	10.18502/ijph.v51i2.8695
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Über subito bestellen

Details ▾
- Kostenpflichtig bestellen

Artikel: Effects of sodium selenite and selenium-enriched yeast on cardiometabolic indices of patients with atherosclerosis: A double-blind randomized clinical trial study.

Khabbaz Koche Ghazi, Mahdiyeh / Ghaffari, Samad / Naemi, Mohammad / Salehi, Rezvaniyeh / Taban Sadeghi, Mohammadreza / Barati, Meisam / Namazi Shabestari, Alireza / Kafil, Behnam / Mesri Alamdari, Naimeh / Soleimanzadeh, Hamid / Tarighat-Esfanjani, Ali / Roshanravan, Neda

Journal of cardiovascular and thoracic research

2021 Band 13, Heft 4, Seite(n) 314–319

Abstract: Introduction: ...

Abstract	Introduction:
Sprache	Englisch
Erscheinungsdatum	2021-12-05
Erscheinungsland	Iran
Dokumenttyp	Journal Article
ZDB-ID	2654729-6
ISSN	2008-6830 ; 2008-5117
ISSN (online)	2008-6830
ISSN	2008-5117
DOI	10.34172/jcvtr.2021.51
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Über subito bestellen

Details ▾
- Kostenpflichtig bestellen

Artikel ; Online: Estimates of incidence, prevalence, mortality, and disability-adjusted life years of lung cancer in Iran, 1990-2019: A systematic analysis from the global burden of disease study 2019.

Shokri Varniab, Zahra / Sharifnejad Tehrani, Yeganeh / Pourabhari Langroudi, Ashkan / Azadnajafabad, Sina / Rezaei, Negar / Rashidi, Mohammad-Mahdi / Esfahani, Zahra / Malekpour, Mohammad-Reza / Ghasemi, Erfan / Ghamari, Azin / Dilmaghani-Marand, Arezou / Mohammadi Fateh, Sahar / Namazi Shabestari, Alireza / Larijani, Bagher / Farzadfar, Farshad

Cancer medicine

2022 Band 11, Heft 23, Seite(n) 4624–4640

Abstract: Background: Lung cancer is one of the leading cancers, with a high burden worldwide. As a developing country, Iran is facing with population growth, widespread tobacco use, demographic and epidemiologic changes, and environmental exposures, which lead ... ...

Abstract	Background: Lung cancer is one of the leading cancers, with a high burden worldwide. As a developing country, Iran is facing with population growth, widespread tobacco use, demographic and epidemiologic changes, and environmental exposures, which lead to cancers becoming a severe concern of public health in Iran. We aimed to examine the burden of lung cancer and its risk factors in Iran. Methods: We utilized the Global Burden of Disease 2019 data and analyzed the total burden of the lung cancer and seven related risk factors by sex, age at national and sub-national levels from 1990 to 2019. Results: The lung cancer age-standardized death rate increased from 11.8 (95% Uncertainty Interval: 9.7-14.4) to 12.9 (11.9-13.9) per 100,000 between 1990 and 2019. This increase was among women from 5 (4.2-7.1) to 8 (7.2-8.8) per 100,000; in contrast, there was a decline among men from 18.5 (14.8-22.6) to 17.8 (16.2-19.4) per 100,000. The burden of lung cancer is concentrated in the advanced age groups. Smoking with 53.5% of total attributable deaths (51.0%-55.9%) was the leading risk factor. At the provincial level, there was a wide range between the lowest and highest, from 8.3 (7.0-10.0) to 19.1 (16.4-22.0) per 100,000 population in the incidence rate and from 8.7 (7.3-10.3) to 20.6 (17.7-24.0) per 100,000 population in mortality rate, respectively in Tehran and West Azerbaijan provinces in 2019. Conclusion: The increasing trend of lung cancer burden among the entire Iranian population, the inter-provincial disparities, and the significant rise in burden of this cancer in women necessitate the urgent implementation and development of policies to prevent and manage lung cancer burden and strategies to reduce exposure to risk factors.
Sprache	Englisch
Erscheinungsdatum	2022-06-13
Erscheinungsland	United States
Dokumenttyp	Journal Article
ZDB-ID	2659751-2
ISSN	2045-7634 ; 2045-7634
ISSN (online)	2045-7634
ISSN	2045-7634
DOI	10.1002/cam4.4792
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Über subito bestellen

Details ▾
- Kostenpflichtig bestellen

Artikel ; Online: Association of Lipid Accumulation Product with Cardio-Metabolic Risk Factors in Postmenopausal Women.

Namazi Shabestari, Alireza / Asadi, Mojgan / Jouyandeh, Zahra / Qorbani, Mostafa / Kelishadi, Roya

Acta medica Iranica

2016 Band 54, Heft 6, Seite(n) 370–375

Abstract: The lipid accumulation product is a novel, safe and inexpensive index of central lipid over accumulation based on waist circumference and fasting concentration of circulating triglycerides. This study was designed to investigate the ability of lipid ... ...

Abstract	The lipid accumulation product is a novel, safe and inexpensive index of central lipid over accumulation based on waist circumference and fasting concentration of circulating triglycerides. This study was designed to investigate the ability of lipid accumulation product to predict Cardio-metabolic risk factors in postmenopausal women. In this Cross-sectional study, 264 postmenopausal women by using convenience sampling method were selected from menopause clinic in Tehran. Cardio-metabolic risk factors were measured, and lipid accumulation product (waist-58×triglycerides [nmol/L]) was calculated. Optimal cut-off point of lipid accumulation product for predicting metabolic syndrome was estimated by ROC (Receiver-operating characteristic) curve analysis. Metabolic syndrome was diagnosed in 41.2% of subjects. Optimal cut-off point of lipid accumulation product for predicting metabolic syndrome was 47.63 (sensitivity:75%; specificity:77.9%). High lipid accumulation product increases risk of all Cardio-metabolic risk factors except overweight, high Total Cholesterol, high Low Density Lipoprotein Cholesterol and high Fasting Blood Sugar in postmenopausal women. Our findings show that lipid accumulation product is associated with metabolic syndrome and some Cardio-metabolic risk factors Also lipid accumulation product may have been a useful tool for predicting cardiovascular disease and metabolic syndrome risk in postmenopausal women.
Mesh-Begriff(e)	Adult ; Body Mass Index ; Cross-Sectional Studies ; Dyslipidemias/blood ; Dyslipidemias/complications ; Female ; Humans ; Incidence ; Iran/epidemiology ; Lipid Accumulation Product/physiology ; Metabolic Syndrome/blood ; Metabolic Syndrome/epidemiology ; Metabolic Syndrome/etiology ; Middle Aged ; Postmenopause/metabolism ; ROC Curve ; Risk Assessment/methods ; Risk Factors ; Triglycerides/blood
Chemische Substanzen	Triglycerides
Sprache	Englisch
Erscheinungsdatum	2016-06
Erscheinungsland	Iran
Dokumenttyp	Journal Article
ZDB-ID	603042-7
ISSN	1735-9694 ; 0044-6025
ISSN (online)	1735-9694
ISSN	0044-6025
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Verfügbar in ZB MED Köln/Königswinter

Zs.A 381: Hefte anzeigen

Standort:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Über subito bestellen

Details ▾
- Im ZB MED-Bestand
- Kostenpflichtig bestellen

Artikel ; Online: Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double-blind randomized trial.

Borhannejad, Firouzeh / Shariati, Behnam / Naderi, Sina / Shalbafan, Mohammadreza / Mortezaei, Amirhosein / Sahebolzamani, Erfan / Saeb, Atefe / Hosein Mortazavi, Seyyed / Kamalzadeh, Leila / Aqamolaei, Ali / Ali Noorbala, Ahmad / Namazi-Shabestari, Alireza / Akhondzadeh, Shahin

Journal of clinical pharmacy and therapeutics

2020 Band 45, Heft 4, Seite(n) 804–811

Abstract: What is known and objective: Major depressive disorder (MDD) is a complex disease and one of the leading contributors to disease burden throughout the world. In the current study, we explored the efficacy and tolerability of vortioxetine versus ... ...

Abstract	What is known and objective: Major depressive disorder (MDD) is a complex disease and one of the leading contributors to disease burden throughout the world. In the current study, we explored the efficacy and tolerability of vortioxetine versus sertraline on symptoms of depression in elderly patients with MDD. Methods: Sixty patients diagnosed with MDD (based on DSM-5) and Hamilton Depression Rating Scale (HAM-D) score ≥ 19 were entered into a randomized double-blind study and were randomized to receive either vortioxetine (15 mg daily) or sertraline (75 mg daily) for six weeks. Patients were assessed using the HAM-D scale at baseline and weeks 3 and 6. Changes in HAM-D score, response rates, remission rate and time to response or remission were also compared between the two study groups. Results and discussion: Fifty patients completed the trial after six weeks. General linear model repeated measures demonstrated no difference in trend of the two treatment groups (P = .897). There was no significantly different improvement in the HDRS scores from baseline to weeks 3 and 6, as well. Differences in response rate, remission rate, time to response and time to remission periods were not statistically significant. Finally, there was not any significantly difference between the two study groups in the frequency of adverse events. What is new and conclusion: This study showed no significant differences in the efficacy and safety of vortioxetine in comparison with sertraline in order for it to be used safely for treatment of major depressive disorder in elderly patients.
Mesh-Begriff(e)	Aged ; Aged, 80 and over ; Depressive Disorder, Major/drug therapy ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Sertraline/adverse effects ; Sertraline/therapeutic use ; Vortioxetine/adverse effects ; Vortioxetine/therapeutic use
Chemische Substanzen	Vortioxetine (3O2K1S3WQV) ; Sertraline (QUC7NX6WMB)
Sprache	Englisch
Erscheinungsdatum	2020-05-18
Erscheinungsland	England
Dokumenttyp	Comparative Study ; Journal Article ; Randomized Controlled Trial
ZDB-ID	639006-7
ISSN	1365-2710 ; 0269-4727
ISSN (online)	1365-2710
ISSN	0269-4727
DOI	10.1111/jcpt.13177
Datenquelle	MEDical Literature Analysis and Retrieval System OnLINE

Volltext online

Zugriff für angemeldete ZB MED Nutzerinnen und Nutzer

Zusatzmaterialien

Verfügbar in ZB MED Köln/Königswinter

Zs.A 1313: Hefte anzeigen

Standort:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Über subito bestellen

Details ▾

Zum Seitenanfang

Ihre letzten Suchen

Zusatzmaterialien

Kategorien

Über subito bestellen

Fernleihe an ZB MED

Zusatzmaterialien

Kategorien

Über subito bestellen

Zusatzmaterialien

Kategorien

Über subito bestellen

Fernleihe an ZB MED

Zusatzmaterialien

Kategorien

Über subito bestellen

Zusatzmaterialien

Kategorien

Über subito bestellen

Zusatzmaterialien

Kategorien

Über subito bestellen

Zusatzmaterialien

Kategorien

Über subito bestellen

Zusatzmaterialien

Kategorien

Über subito bestellen

Zusatzmaterialien

Kategorien

Verfügbar in ZB MED Köln/Königswinter

Über subito bestellen

Volltext online

Zusatzmaterialien

Kategorien

Verfügbar in ZB MED Köln/Königswinter

Über subito bestellen